PeptideStack
5.2kquestions
20kanswers
220users

How do I compute the +4 charge state m/z for a peptide of 4207.2 Da?

Asked 8 Aug 2024Modified 21 months agoViewed 65k times
39

The specifics, since they change the answer: +4 · 4207.2 Da.

I would like the arithmetic checked rather than the conclusion asserted.

I have deliberately not used an online calculator because I want to be able to check the result.

Can someone walk through the arithmetic step by step?

mass-spec
mass-spec

Mass spectrometry for identity confirmation: electrospray ionisation, multiple charge states, monoisotopic versus average mass, deconvolution, and…

38 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
shareeditfollowflag
DK
askeddermot_kiely14k178 Aug 2024
5Adding for future readers: the certificate should carry the lot number, not just a batch code. – mz_4113 33 days ago
add a comment

5 Answers

Accepted answer first, then by votes
46

Accepted answer

Mass spectrometry is an identity technique, not a purity technique, and conflating the two is a common source of false confidence.

The m/z accuracy achievable depends on the mass analyser type — quadrupole gives low accuracy, time-of-flight gives moderate accuracy, and Orbitrap gives high accuracy.

Reconciling gross mass to label claim

ComponentTypical shareCounted in purity?Counted in content?
Target peptide88–94 %Yes, as main peakYes
Related impurities1–3 %Yes, as other peaksNo
Counter-ion (TFA or acetate)2–8 %NoNo
Residual water2–6 %NoNo
Bulking agent, if present0–40 %NoNo

For a large peptide with multiple peaks in the mass spectrum, comparing the observed isotope pattern to the calculated pattern is a quick check that the formula matches.

False positives from contamination are common in mass spectrometry work, and running a blank between every sample and a solvent background are standard practice.

The caveat is that a correct mass does not mean the peak is correct — isomers and co-eluting species can have the same m/z.

The practical summary: use mass spectrometry for identity, not for purity.

shareimprove this answerflag
SH
answered · acceptedseven_day_half16k1816 Oct 2024
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
38

The part that matters: source contamination and carry-over between samples are the failure modes most specific to mass spectrometry, and they are invisible without a blank injection between samples.

The baseline noise on a mass spectrum sets the limit of detection, and a weak signal close to the noise is not reliable evidence for the presence of a species.

A mass shift of plus one usually means deamidation at asparagine or glutamine, which creates a secondary amine instead of an amide and changes the mass by exactly one.

I would not trust a mass result without a good baseline and a blank injection check.

A correct mass is necessary for identity but not sufficient — you also need the chromatography to confirm it.

shareimprove this answerflag
IB
answeredilaria_bertone43k3827 Oct 2024
17

Scrambled disulfides have the same mass as correctly formed ones, so mass spectrometry alone cannot detect a scrambling failure.

High-resolution mass spectrometry can distinguish a Lys-containing peptide from an Arg-containing peptide of similar mass because of the isotope difference.

On the detail: a mass shift of minus one hundred and twenty-eight usually means a missing Gln or Lys residue from a synthesis deletion sequence.

Peptide mapping — enzymatic digestion followed by tandem mass spectrometry — can confirm the primary sequence and is the method of choice when identity is ambiguous.

One qualification: high-resolution mass spectrometry gives high mass accuracy but low speed, and the reverse is true for low-resolution instruments.

Always run a blank between samples and check for carry-over.

edited 11 Oct 2024 by cap_the_luer — clarified the distinction between purity and content

shareimprove this answerflag
CL
answeredcap_the_luer15k285 Oct 2024
Good answer, but the confidence interval in the cited trial is wider than implied. – net_peptide 25 days ago
add a comment
15

The single most important fact about mass spectrometry for peptides is that it measures only the molecular weight and tells you almost nothing about whether the peak is actually your target.

The charge state distribution depends on the solution pH, the structure of the peptide and the source conditions, so the same peptide can look different under different conditions.

The practical summary: use mass spectrometry for identity, not for purity.

shareimprove this answerflag
RC
answeredRP_C1885k15813 Sept 2024
3Adding for future readers: the certificate should carry the lot number, not just a batch code. – Dr_Lena_Ostrowska 7 months ago
add a comment
15

Start from what electrospray ionisation does: it ionises the peptide without fragmenting it, creating singly or multiply charged species that the mass analyser then separates by their mass-to-charge ratio.

A monoisotopic mass includes only the lightest isotope of each element, while the average mass weights by natural isotope abundance, and small peptides use monoisotopic mass.

Electrospray ionisation soft-ionisation behaviour is well-characterised and standards exist for m/z calibration and mass accuracy assessment.

A correct mass is necessary for identity but not sufficient — you also need the chromatography to confirm it.

shareimprove this answerflag
ED
answerede_dziedzic87k24824 Sept 2024
8I would gently push back on the second point — the evidence there is thinner than stated. – pip_okonjo 9 months ago
7Adding for future readers: the certificate should carry the lot number, not just a batch code. – lyoph_cake 8 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.